U-Blot® Research Grade FasinumabCat. No. WA2848$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade FasinumabCat. No. WA2848
U-Blot® Research Grade FarletuzumabCat. No. WA2847
U-Blot® Research Grade FaricimabCat. No. WA2846
U-Blot® Research Grade FaralimomabCat. No. WA2845
U-Blot® Research Grade FanolesomabCat. No. WA2844
U-Blot® Research Grade FanastomigCat. No. WA2843
U-Blot® Research Grade FalbikitugCat. No. WA2842
U-Blot® Research Grade Fabrazyme/Agalsidase AlfaCat. No. WA2841
U-Blot® Research Grade EzabenlimabCat. No. WA2840
U-Blot® Research Grade ExlinkibartCat. No. WA2839
U-Blot® Research Grade exerenibartCat. No. WA2838
U-Blot® Research Grade ExbivirumabCat. No. WA2837